Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 5,500 shares at $56.42 ($308K) on 2018-08-09, disclosed to the SEC on 2018-08-10.
Scheduled sale ($308k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.51 | 3,000 | $167K | 54.1% |
| 2 | $56.42 | 2,500 | $141K | 45.9% |
| Total | $55.92 avg | 5,500 | $308K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |